InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,920.61
(
1.64%
)
Post# of 43716
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

drkazmd65

Send PM Follow Ignore
Followers 61
Posts 7519
Boards Moderated 2
Alias Born 02/10/2010

drkazmd65

Re: tprosuper post# 6172

Friday, 07/11/2014 11:04:43 AM

Friday, July 11, 2014 11:04:43 AM

Post# of 43716
LEAPS is on the back burner while CVM focuses on the Multikine work already in clinical trials,.... Which is a wise move for a company with limited resources trying to break through into being a revenue generator.

But it remains nice to see something about LEAPS now and again.

LEAPS probably has the higher long-term potential when compared to Multikine - as it is more flexible as to what it could be applied to. BUT was much further away from being applied.

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CVM News
More CVM News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!